What is the latest news on SNDX?
S
What is the latest news on SNDX?
🦉
Latest News & Events — SNDX
25 articles in the past 30 days
Top Stories
Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
GlobeNewsWire-FDA ·
GlobeNewsWire-FDA ·
Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition
GlobeNewsWire-FDA ·
GlobeNewsWire-FDA ·
Stifel raises Syndax Pharmaceuticals stock price target on therapy outlook By Investing.com - Investing.com Canada
Google News ·
Google News ·
Syndax Pharmaceuticals (SNDX) Is Down 10.7% After Revenue Surges And Loss Narrows In Q1 2026 - simplywall.st
Google News ·
Google News ·
Syndax Pharmaceuticals (SNDX) Narrows Q1 Loss To US$42.7 Million Challenging Bearish Narratives - simplywall.st
Google News ·
Google News ·
Syndax (SNDX) Narrows Losses as Revuforj and Niktimvo Gain Traction - What’s Really Shifting?
Yahoo Finance ·
Yahoo Finance ·
Analyst Actions
| Firm | Action | Date |
|---|---|---|
SEC Form 8-K Filings (1 in 90 days)
—